A randomized, double-blind, Phase 2 study to evaluate subjective and objective outcomes in patients with acute bacterial skin and skin structure infections treated with delafloxacin, linezolid or vancomycin

OBJECTIVES: Delafloxacin is an investigational anionic fluoroquinolone being developed to treat infections caused by Gram-positive and -negative organisms. This clinical trial evaluated the efficacy and safety of delafloxacin in the treatment of acute bacterial skin and skin structure infections (AB...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Antimicrob Chemother
Autores principales: Kingsley, Jeff, Mehra, Purvi, Lawrence, Laura E., Henry, Eugenia, Duffy, Erin, Cammarata, Sue K., Pullman, John
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2016
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4743703/
https://ncbi.nlm.nih.gov/pubmed/26679243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkv411
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares